dc.contributor.author | Kılıç, Mehmet | |
dc.contributor.author | Orhun, Günseli | |
dc.contributor.author | Çeliksoy, Emre | |
dc.contributor.author | Mercan, Mutlu | |
dc.contributor.author | Tükek, Tufan | |
dc.contributor.author | Esen, Figen | |
dc.contributor.author | Ergin Özcan, Perihan | |
dc.contributor.author | Polat, Özlem | |
dc.contributor.author | Anaklı, İlkay | |
dc.contributor.author | Alay, Gülsüm | |
dc.contributor.author | Tuna, Verda | |
dc.date.accessioned | 2021-12-10T10:35:17Z | |
dc.date.available | 2021-12-10T10:35:17Z | |
dc.identifier.citation | Esen F., Ergin Özcan P., Orhun G., Polat Ö., Anaklı İ., Alay G., Tuna V., Çeliksoy E., Kılıç M., Mercan M., et al., "Effects of intravenous immunoglobulin (IVIG) on the course of severe COVID‑19: results from a retrospective data analysis of a patient cohort in Turkey treated with or without Octagam®.", 33th ESICM Annual Congress, 6 - 09 Aralık 2020, ss.300 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_48888687-fcf7-4de2-888d-b4daacbc00b9 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/170188 | |
dc.identifier.uri | https://doi.org/10.1186/s40635-020-00354-8 | |
dc.language.iso | eng | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.title | Effects of intravenous immunoglobulin (IVIG) on the course of severe COVID‑19: results from a retrospective data analysis of a patient cohort in Turkey treated with or without Octagam®. | |
dc.type | Bildiri | |
dc.contributor.department | İstanbul Üniversitesi , İstanbul Tıp Fakültesi , Cerrahi Tıp Bilimleri Bölümü | |
dc.contributor.firstauthorID | 2607349 | |